Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories-Reference-Cited by-同舟云学术

Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories

Published:2022-02-09 Issue:3 Volume:96 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Malicoat Johnny¹,Manivasagam Senthamizharasi¹,Zuñiga Sonia²,Sola Isabel²,McCabe Dianne¹,Rong Lijun³,Perlman Stanley¹^ORCID,Enjuanes Luis²^ORCID,Manicassamy Balaji¹^ORCID

Affiliation:

1. Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA

2. Coronavirus Laboratory, Departamento Biologia Molecular y Celular, Centro Nacional de Biotecnologia (CNB-CSIC), Madrid, Spain

3. Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, Illinois, USA

Abstract

Due to the highly contagious nature of SARS-CoV-2 and the lack of immunity in the human population, research on SARS-CoV-2 has been restricted to biosafety level 3 laboratories. This has greatly limited participation of the broader scientific community in SARS-CoV-2 research and thus has hindered the development of vaccines and antiviral drugs.

Funder

COVID Pilot Grant - Carver Trust- University of Iowa

Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/jvi.01837-21

Reference19 articles.

1. Assessment of high-throughput screening (HTS) methods for high-consequence pathogens;Friedrich BM;J Bioterror Biodef,2011

2. Adapting High-Throughput Screening Methods and Assays for Biocontainment Laboratories

3. Federal Select Agent Program. Select agents and toxins exclusions: excluded attenuated strains of HHS select agents section 73.3 (e). https://www.selectagents.gov/sat/exclusions/hhs.htm.

4. Identification of interferon-stimulated genes that attenuate Ebola virus infection

5. Biosafety recommendations for work with influenza viruses containing a hemagglutinin from the A/goose/Guangdong/1/96 lineage;Gangadharan D;MMWR Recommend Rep,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conserved role of spike S2 domain N-glycosylation across beta-coronavirus family;2024-09-05

2. Increased production of orthoflavivirus single-round infectious particles produced in mammalian cells at a suboptimal culture temperature of 28°C;Journal of Virological Methods;2024-09

3. A detailed protocol for generating spike trans-complemented SARS-CoV-2 replicons;2024-07-30

4. A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation;Journal of Virology;2024-07-23

5. Novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle;Emerging Microbes & Infections;2024-07-05